Scale with confidence. From early pharma development to full production, Hosokawa Micron Ltd provides a GMP-compliant processing environment tailored to your exact material formulation specifications.
Pharmaceutical processing demands precision, compliance and absolute consistency. Hosokawa Micron’s contract processing service gives businesses access to our industry-leading size reduction and powder characterisation technologies, without the need to invest in specialist machinery or personnel.
From early stage development through to full commercial production, our experienced team works to your exact material specifications within a strictly controlled, compliant processing environment.
Contract processing services for the pharmaceutical industry provide benefits in flexibility, speed, and cost savings.
Enhanced Regulatory Compliance & Safety
Third-party pharmaceutical partners support regulatory, safety, and maintenance compliance, ensuring strict standards that protect product efficacy and manufacturing reliability.
Advanced Processing Expertise
Contract manufacturing provides access to advanced pharmaceutical technologies, specialist equipment, and expert partners, supporting businesses without in-house expertise or facilities.
Scalability & Production Flexibility
Contract manufacturing helps pharmaceutical businesses meet fluctuating needs by increasing production based on demand and allowing organisations to scale up quickly.
Speed-To-Market & Production
Working with external partners increases flexibility and speeds market entry, reducing bottlenecks and accelerating drugs from concept to commercialisation without the need to wait for capital investment.
Cost Efficiency
Outsourcing contract manufacturing enables pharmaceutical businesses to avoid investing in expensive, specialised in-house processing machinery.
Reliability & Contingency Planning
Outsourcing provides safety by supporting production during shutdowns, disasters, or emergencies, helping businesses maintain brand value and customer delivery.
Want to discover more? Our guide to outsourced pharmaceutical powder contract manufacturing and material classification tells you all you need to know.
This guide shows businesses, from start-ups to large-scale operations, how outsourcing contract manufacturing to expert third parties enhances product efficacy and supports scalable growth.
From particle size reduction to powder characterisation, our processing technologies are selected and operated to meet the stringent requirements of pharmaceutical manufacturing.
Explore our full range of capabilities below:
The Mechano Fusion System AMS uses mechanical energy to fuse and modify fine powders without heat.
The Nobilta 100 Super High Shear Mixer uses intense mechanical forces to mix, coat, and fuse fine powders into uniform composite particles in a single dry process.
The Multiprocessor is a modular powder processing system combining different milling and classification units to grind, refine, and control particle size using interchangeable processes.
A Containment Isolator is a sealed system that allows safe handling of hazardous materials by isolating them from the operator and environment.
The 100AS and 50AS Jet Mills use high‑velocity air streams to accelerate and collide particles, achieving ultra‑fine grinding without mechanical contact. This clean, contamination‑free process produces consistently narrow particle size distributions ideal for high‑purity applications.
The 100 UPZ Pin Mill uses high‑speed rotational forces to grind, impact, and reduce materials into fine, uniform particles with precise control. Its versatile design allows for flexible processing of a wide range of materials in a single, efficient milling step.
We use advanced particle size analysis equipment, including the Air Jet Sieve e200LS, Sympatec systems, Powder Tester PT-X, and Malvern Mastersizer 3000. We also test for allergens, microbial content, and assay as part of our certificate of performance.
Every pharmaceutical contract manufacturing project we undertake at Hosokawa Micron Ltd follows a structured, transparent process designed to give you complete confidence from initial enquiry through to final delivery. Our customer journey is built around collaboration, precision and clear communication at every stage, ensuring your material is processed safely, compliantly and to your exact specifications.
Whether you are exploring contract manufacturing for the first time, returning to us for repeat production or looking to transition into full scale contract manufacturing, our experienced team will guide you through every step of the process.
Still looking for answers? Learn more about our contract manufacturing services for pharmaceuticals with our frequently asked questions below.
Pharmaceutical contract manufacturing is when a drug manufacturer or formulator partners with a specialist third-party provider to carry out specific processing steps on their behalf, using the provider’s equipment, expertise and compliant facilities.
We offer a range of size reduction and powder characterisation services for the pharmaceutical industry, including milling, micronising, Mechanofusion™, classification and blending. Our team will work with you to identify the most appropriate process for your compound and specification requirements.
Our facilities and processes operate in accordance with Good Manufacturing Practice guidelines, ensuring that all pharmaceutical processing is carried out within a controlled, compliant and fully documented environment.
Responsibility is shared between both parties. Hosokawa Micron is responsible for operating GMP standards and agreed quality specifications, while the client retains responsibility for ensuring the contracted process meets the wider regulatory requirements for their product.
Please contact our team to discuss your specific material requirements. We will assess the suitability of your compound against our facility capabilities and safety protocols before any processing begins.
We operate with defined and validated processing parameters, with full documentation and traceability maintained throughout each production run. This ensures that every batch meets your agreed specifications consistently and reliably.
Yes. We work with pharmaceutical businesses at every stage, from small-scale feasibility trials and formulation development through to full commercial production volumes, providing a flexible service that grows with your requirements.
We follow strict cleaning and changeover procedures between production runs, with documented verification to ensure there is no risk of cross-contamination between materials or batches.
We provide comprehensive batch documentation, processing records and certificates of conformance as standard. Our documentation processes are designed to support your own regulatory submissions and quality management requirements. Our equipment is fully validated for use over the minimum and maximum operating conditions.
We offer a range of secure packaging options, including sacks, drums, hermetically sealed vacuum foil, ensuring your processed materials are packaged safely, compliantly and in line with your specific requirements.
Contact our team with details of your compound, processing requirements and target specifications. We will guide you through the process, including any feasibility assessments or trials required before full production begins.
Our milling and classification technologies are capable of achieving a wide range of particle sizes, from coarse granules through to fine micronised powders. Our team will work with you to establish the target particle size distribution required for your formulation.
Micronisation is a size reduction process that produces very fine particles. It is commonly used in pharmaceutical manufacturing to improve the bioavailability, solubility and absorption of active pharmaceutical ingredients.
Equipment validation is carried out in accordance with GMP requirements, including installation qualification, operational qualification and performance qualification using surrogate materials. Full validation documentation is maintained and available to support your regulatory requirements.
Particle size distribution directly affects the performance of a pharmaceutical product, influencing dissolution rate, bioavailability, content uniformity and processability. Achieving a consistent and controlled particle size distribution is therefore critical to product efficacy and regulatory compliance.
We carry out a range of powder characterisation analyses, including particle size distribution, bulk and tapped density, and flowability. These measurements help establish baseline material properties and verify that processing has achieved the required specifications.
Certain pharmaceutical powders present handling challenges due to static charge or cohesive behaviour. Our team has experience managing these material characteristics and will select the most appropriate processing approach and equipment configuration to ensure reliable and consistent results.
Air classification is used to separate particles by size and density. In pharmaceutical processing, it is particularly useful for achieving tight particle size distributions and removing fines or oversized particles that could affect product performance.
Our experienced team is on hand to discuss your compound, processing requirements and specifications.